Lv2
130 积分 2021-09-23 加入
Pulmonary langerhans cell histiocytosis following resection of lung adenocarcinoma: a case report and diagnostic challenges
10小时前
已关闭
Ivonescimab monotherapy in an elderly patient with EGFR-TKI-resistant advanced lung adenocarcinoma and pericardial effusion: a case report and literature review
10小时前
已关闭
A novel HEAT repeat protein 5B anaplastic lymphoma kinase fusion in lung adenocarcinoma confers sensitivity to ensartinib
1个月前
已关闭
Thoracic radiotherapy synergizes with first‐line EGFR ‐ TKIs in advanced EGFR ‐mutant NSCLC : A dual‐center real‐world study
2个月前
已完结
Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase–driven non-small cell lung cancer therapy
3个月前
已完结
962eP Befotertinib (D-0316) plus icotinib as first-line therapy for patients with EGFR-mutated advanced non-small-cell lung cancer
3个月前
已关闭
Safety and Efficacy of the Oral IL-23 Receptor Antagonist Icotrokinra for Plaque Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
3个月前
已完结
Efficacy and Safety of Aumolertinib/Icotinib Combination Therapy for Naive EGFR -Mutant NSCLC Patients with Brain Metastases: A Phase I/II Study
3个月前
已完结
1081eP EGFR exon 19 duplications/insertions, rare but potential therapeutic targets for NSCLC: A real-world study and pooled analysis of case series
3个月前
已关闭
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer
3个月前
已关闭
皖公网安备34019202002308
